Suraj Kalia

Stock Analyst at Oppenheimer

(3.62)
# 764
Out of 4,884 analysts
79
Total ratings
45.59%
Success rate
8.46%
Average return

Stocks Rated by Suraj Kalia

TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130$150
Current: $126.11
Upside: +18.95%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36$45
Current: $31.90
Upside: +41.09%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30$23
Current: $8.74
Upside: +163.16%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105$120
Current: $142.31
Upside: -15.68%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30$32
Current: $30.53
Upside: +4.83%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90$93
Current: $83.97
Upside: +10.75%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $134.28
Upside: -3.19%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $5.07
Upside: +97.24%
Edwards Lifesciences
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $76.49
Upside: +17.66%
Nyxoah
Aug 7, 2024
Maintains: Outperform
Price Target: $15$13
Current: $7.75
Upside: +67.74%
Initiates: Outperform
Price Target: $135
Current: $119.64
Upside: +12.84%
Downgrades: Perform
Price Target: n/a
Current: $257.25
Upside: -
Maintains: Outperform
Price Target: $24$30
Current: $10.09
Upside: +197.32%
Maintains: Outperform
Price Target: $16$10
Current: $0.18
Upside: +5,418.76%
Initiates: Outperform
Price Target: $97
Current: $76.17
Upside: +27.35%
Reiterates: Outperform
Price Target: $28
Current: $22.32
Upside: +25.48%
Initiates: Outperform
Price Target: $4.5
Current: $1.91
Upside: +135.60%
Initiates: Outperform
Price Target: $16
Current: $2.21
Upside: +625.62%
Upgrades: Perform
Price Target: n/a
Current: $542.71
Upside: -
Upgrades: Outperform
Price Target: $660
Current: $2.49
Upside: +26,406.02%
Upgrades: Perform
Price Target: n/a
Current: $129.50
Upside: -
Initiates: Perform
Price Target: n/a
Current: $5.14
Upside: -
Initiates: Outperform
Price Target: $100
Current: $30.61
Upside: +226.69%
Upgrades: Market Perform
Price Target: n/a
Current: $83.02
Upside: -